Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Oxford Nanopore Technologies PLC ( (GB:ONT) ) has shared an announcement.
Oxford Nanopore Technologies plc, listed on the London Stock Exchange as ONT, develops nanopore-based molecular sensing technology for real-time analysis of DNA and RNA. Its platforms are used in more than 125 countries across healthcare, research, and agriculture, helping scientists and clinicians study humans, plants, animals, microbes, and diseases such as cancer.
The company announced the publication of its Annual Report and Accounts for the year ended 31 December 2025 and the Notice of its 2026 Annual General Meeting. The AGM will take place on 4 June 2026 at the company’s Oxford Science Park offices, with shareholders able to access documents online and encouraged to submit proxy votes in advance, underscoring ongoing engagement with investors and compliance with U.K. listing requirements.
The most recent analyst rating on (GB:ONT) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Oxford Nanopore Technologies PLC stock, see the GB:ONT Stock Forecast page.
Spark’s Take on ONT Stock
According to Spark, TipRanks’ AI Analyst, ONT is a Neutral.
The score is held back primarily by weak financial performance—large ongoing losses and continued cash burn—despite improving revenue growth and solid gross margins. Technicals also detract due to a clear downtrend (below major moving averages and negative MACD). Offsetting factors include constructive earnings-call guidance with margin/OpEx discipline and a credible longer-term breakeven timeline, plus a relatively low-leverage balance sheet.
To see Spark’s full report on ONT stock, click here.
More about Oxford Nanopore Technologies PLC
Oxford Nanopore Technologies plc, listed on the London Stock Exchange as ONT, develops nanopore-based molecular sensing technology for real-time analysis of DNA and RNA. Its platforms are used in more than 125 countries across healthcare, research, and agriculture, helping scientists and clinicians study humans, plants, animals, microbes, and diseases such as cancer.
The company positions its technology as accessible, scalable, and capable of delivering rapid biological insights, with potential applications spanning healthcare, food safety, and environmental monitoring. This broad market focus underpins its strategy to enable the analysis of “anything, by anyone, anywhere,” supporting both academic and commercial users globally.
Average Trading Volume: 1,735,469
Technical Sentiment Signal: Sell
Current Market Cap: £1.05B
For detailed information about ONT stock, go to TipRanks’ Stock Analysis page.